4
Changes in Ownership
Lipocine Inc. Filed Acc 0001638599-18-000030
Chief Commercial Officer sold 3,750 shares at $3.47 ($13,023)
- Chief Commercial Officer acquired 9,375 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bass Gregory Brooks Chief Commercial Officer | 2017-12-29 | Option exercise | +9,375 | 9,375 | D | ||
| Bass Gregory Brooks Chief Commercial Officer | 2017-12-29 | Sale | −3,750 | $3.47 | $13,023 | 5,625 | D |
| Derivatives | |||||||
| Bass Gregory Brooks Chief Commercial Officer | 2017-12-29 | Option exercise · Restricted Stock Unit | −9,375 | 28,125 | D | ||
| Open-market sales · 3,750 sh · avg $3.47 · $13,023 | |||||||
Loading xslF345X03/doc4_5170.xml…